Whereas cigarette smoking remains one of the most preventable forms of noncommunicable disease in the United States; Whereas, according to the Centers for Disease Control and Prevention— (1) approximately 28,300,000 Americans smoke cigarettes on a regular basis and more than 16,000,000 Americans live with a smoking-related disease; (2) approximately 27 of every 100 American Indian/Alaska Native adults, approximately 12 of every 100 non-Hispanic African-American adults, approximately 8 of every 100 Hispanic adults, and approximately 5 of every 100 non-Hispanic Asian adults are current cigarette smokers; (3) approximately 20 of every 100 adults with a household income less than $35,000 a year and approximately 14 of every 100 adults with a household income between $35,000 and $74,999.99 are current smokers; and (4) approximately 3 in 10 United States military veterans used some form of tobacco product during their service, and smoking amongst United States veterans is more than double the national average; Whereas the best health outcome for current smokers is to quit altogether; however the Centers for Disease Control and Prevention estimates less than 10 percent of adult smokers will successfully stop smoking cigarettes in a given year; Whereas the bipartisan Family Smoking Prevention and Tobacco Control Act (P.L. 111–31), enacted in 2009, provided the Food and Drug Administration (FDA) authority to regulate the tobacco industry and develop regulatory pathways to bring scientifically substantiated less harmful alternatives to the market for adult consumers who will otherwise continue smoking cigarettes; Whereas the FDA has adopted an unduly narrow interpretation of the Appropriate for the Protection of Public Health standard set forth in such Act, which contemplated FDA authorizing proven reduced-harm alternatives for adult smokers and using FDA’s substantial post-market regulatory controls to protect against future population risks